BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9098200)

  • 1. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
    Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.
    Kurata C; Wakabayashi Y; Shouda S; Mikami T; Takei Y; Tawarahara K; Sugiyama T; Nakano T; Fujisawa S; Andoh A
    J Nucl Med; 1997 Jul; 38(7):1079-84. PubMed ID: 9225794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMIPP compared with PET metabolism.
    Tadamura E; Tamaki N; Kudoh T; Hattori N; Konishi J
    Int J Card Imaging; 1999 Feb; 15(1):61-9. PubMed ID: 10453404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
    Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
    J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease.
    Fujiwara S; Takeishi Y; Atsumi H; Takahashi K; Tomoike H
    J Nucl Med; 1997 Feb; 38(2):175-80. PubMed ID: 9025730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of ischemic but viable myocardium using a new 18F-labeled 2-nitroimidazole analog, 18F-FRP170.
    Kaneta T; Takai Y; Kagaya Y; Yamane Y; Wada H; Yuki M; Iwata R; Tsujitani M; Takahashi S; Yamada S
    J Nucl Med; 2002 Jan; 43(1):109-16. PubMed ID: 11801713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency).
    Fukuchi K; Nozaki S; Yoshizumi T; Hasegawa S; Uehara T; Nakagawa T; Kobayashi T; Tomiyama Y; Yamashita S; Matsuzawa Y; Nishimura T
    J Nucl Med; 1999 Feb; 40(2):239-43. PubMed ID: 10025829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial metabolism of 123I-BMIPP during low-flow ischaemia in an experimental model: comparison with myocardial blood flow and 18F-FDG.
    Hosokawa R; Nohara R; Fujibayashi Y; Hirai T; Fujita M; Magata Y; Tadamura E; Konishi J; Sasayama S
    Eur J Nucl Med; 2001 Nov; 28(11):1630-9. PubMed ID: 11702104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of myocardial uptake of iodine 123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography.
    Kawamoto M; Tamaki N; Yonekura Y; Magata Y; Tadamura E; Nohara R; Matsumori A; Sasayama S; Konishi J
    J Nucl Cardiol; 1994; 1(6):522-8. PubMed ID: 9420746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy.
    Wakasugi S; Fischman AJ; Babich JW; Callahan RJ; Elmaleh DR; Wilkinson R; Strauss HW
    J Nucl Med; 1993 Sep; 34(9):1529-35. PubMed ID: 8355075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction.
    Yamagishi H; Akioka K; Takagi M; Tanaka A; Takeuchi K; Yoshikawa J; Ochi H
    Heart; 1998 Jul; 80(1):28-34. PubMed ID: 9764055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
    Mori H; Sakamoto T; Ueda Y; Yano K
    J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prediction of left ventricular functional recovery in patients with acute myocardial infarction using single photon emission computed tomography with thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid].
    Hashimoto A; Nakata T; Nagao K; Kobayashi H; Hase M; Yoshioka N; Tsuchihashi K; Yonekura S; Tanaka S; Iimura O
    J Cardiol; 1995 Aug; 26(2):59-68. PubMed ID: 7674145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between discrepant areas on 201TlCl/123I-BMIPP myocardial scintigraphy, local wall motion, and glucose metabolism in patients with myocardial infarction].
    Tanaka A
    Kaku Igaku; 1998 Nov; 35(9):857-69. PubMed ID: 9916402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.